| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| CARREL MICHAEL H | President, CEO, & Director, Director | 7555 INNOVATION WAY, MASON | /s/ Michael H. Carrel | 03 Mar 2026 | 0001230584 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ATRC | Common Stock | Award | $0 | +68,618 | +10% | $0.000000 | 755,995 | 01 Mar 2026 | Direct | F1 |
| transaction | ATRC | Common Stock | Award | $0 | +101,280 | +13% | $0.000000 | 857,275 | 01 Mar 2026 | Direct | F2 |
| transaction | ATRC | Common Stock | Tax liability | $2,275,009 | -72,777 | -8.5% | $31.26 | 784,498 | 01 Mar 2026 | Direct | F3 |
| holding | ATRC | Common Stock | 9,310 | 01 Mar 2026 | Held by reporting person's children | F4 | |||||
| holding | ATRC | Common Stock | 2,250 | 01 Mar 2026 | Held by reporting person's parents | F4 |
| Id | Content |
|---|---|
| F1 | The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. |
| F2 | The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met. |
| F3 | The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award. |
| F4 | The reporting person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein. |